Related Experiment Video
Updated: Aug 9, 2026

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
Published on: July 25, 2011
Interferon gamma induced oncolysis. An effect on head and neck squamous carcinoma cultures
1Johns Hopkins Medical Institutions, Baltimore, MD 21205.
Abstract:
We have measured an oncolytic effect of recombinant human interferon gamma on squamous cell carcinoma (SCC) tissue cultures. The decrease in viable cells from an established culture was visually observed directly and measured by the loss of cell protein mass as determined by the staining of cultures with naphthol blue-black dye. We avoided confusion with tumor necrosis factor effects by using recombinant human interferon gamma cloned from a single gene as opposed to natural human interferon gamma. Oncolysis induced by recombinant human interferon gamma requires four days after exposure for a significant loss of total cellular protein to be measured, although changes can be observed visually after one day. This sensitivity to recombinant human interferon gamma was observed in SCC cultures obtained from head and neck mucosa, in addition to those from cervix and skin. Several head and neck cultures are sensitive to the oncolytic effect of recombinant human interferon gamma at less than 30 U/mL concentration. The actual time of treatment observations dictates changes in current recombinant human interferon gamma treatment regimens if the oncolytic effect is desired.
Insights
Recombinant human interferon gamma shows an oncolytic effect on squamous cell carcinoma (SCC) tissue cultures. This finding suggests potential new therapeutic strategies for SCC by utilizing interferon gamma for cancer treatment.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Squamous cell carcinoma (SCC) is a common cancer.
- Interferon gamma (IFN-γ) is a cytokine with known immune-modulating properties.
- The direct oncolytic potential of recombinant human interferon gamma (rhIFN-γ) on SCC requires further elucidation.
Purpose of the Study:
- To investigate the direct oncolytic effect of rhIFN-γ on various squamous cell carcinoma (SCC) tissue cultures.
- To quantify the cellular changes induced by rhIFN-γ exposure in SCC models.
- To determine the sensitivity of different SCC origins to rhIFN-γ mediated oncolysis.
Main Methods:
- Utilized established SCC tissue cultures from head and neck mucosa, cervix, and skin.
- Exposed cultures to rhIFN-γ and observed visual changes.
- Quantified viable cell loss by measuring total cellular protein mass using naphthol blue-black dye staining.
- Differentiated rhIFN-γ effects from tumor necrosis factor by using a single-gene cloned recombinant form.
Main Results:
- rhIFN-γ demonstrated a measurable oncolytic effect on SCC tissue cultures.
- Significant loss of total cellular protein was observed four days post-exposure, with visual changes noted after one day.
- SCC cultures from head and neck, cervix, and skin exhibited sensitivity to rhIFN-γ.
- Head and neck SCC cultures showed sensitivity at concentrations below 30 U/mL.
Conclusions:
- Recombinant human interferon gamma possesses direct oncolytic activity against squamous cell carcinoma.
- The timing of rhIFN-γ exposure is critical for achieving desired oncolytic effects in treatment regimens.
- rhIFN-γ represents a potential therapeutic agent for treating various types of SCC.
More Related Videos
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Inhibitors of Viral Protein Synthesis

